All Hands On Deck - Oral!

Discussion in 'Novo Nordisk' started by anonymous, Jul 14, 2019 at 2:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So it's an orgy! Whoo Hoo, just like the old days. We all get oral! What will the product percentages be? What will the payer contracts be? Will they price it like an oral or like a GLP1? How will we maintain our insulin business? So many products declining. Can we really make this company soar on the wings on 1 product?
     

  2. anonymous

    anonymous Guest

    There is no way they will have everyone sell the oral, when the BIG O is doing so well. Would be insanity. Sell the bird in hand!!!!
     
  3. anonymous

    anonymous Guest

    Just think, 3 people selling the same drug, that’ll last
     
  4. anonymous

    anonymous Guest

    three in any pod promoting one product will not work
    Period
     
  5. anonymous

    anonymous Guest

    Luckily for us, there is more than just your pod at this company. Pretty sure no big decisions are being made based upon you and you alone.
     
  6. anonymous

    anonymous Guest

  7. anonymous

    anonymous Guest

  8. anonymous

    anonymous Guest

    HR insider here....large realignment/layoffs Q4....it is confirmed....make future plans accordingly...Re43 Sax...
     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    What does the Re43 Sax mean??
     
  11. anonymous

    anonymous Guest

    my Endo told me an oral doesn’t get him reimbursed as much so u less you have a speaker good luck
     
  12. anonymous

    anonymous Guest

    What on earth are you talking about? These are not buy-and-bill products FYI. He is probably talking about some other inj therapies which he makes money from via buy-and-bill ( the office purchases product and supplies to the pt. then bills insurance directly, netting them a spread or profit on such goods).

    Also to the other poster nice work bringing up a breaking news story from April 2.